Trial Profile
A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2022
Price :
$35
*
At a glance
- Drugs Lidocaine/tetracaine (Primary)
- Indications Procedural pain
- Focus Adverse reactions
- Sponsors Galderma; Q-Med
- 02 Mar 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 08 Nov 2013 Planned End Date changed from 1 Jun 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 02 Mar 2013 New trial record